InsidersTradesSigma
Follow the NH농우바이오 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Food & Beverage sector, NH농우바이오 has published 4 public disclosures. Market capitalisation: €669.5bn. The latest transaction was filed on 17 March 2022 (Other). Among the most active insiders: NH농우바이오. The full history is free.
Analysts rate NH농우바이오 Buy (bullish), based on 6 analysts. Average price target: ₩23,717.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.